Incidence & assessment of tranexamic acid in reducing postpartum bleeding in pre eclampsia patients undergoing LSCS
Phase 2
- Conditions
- Health Condition 1: O72- Postpartum hemorrhage
- Registration Number
- CTRI/2023/10/059089
- Lead Sponsor
- Command hospital Central Command Lucknow
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Pregnant women with period of gestation 37-42 weeks with documented pre-eclampsia as per ACOG criteria
Exclusion Criteria
moderate anemia (Hb <10 gm%),
Patient on anticoagulation,
Eclampsia,
ASA III & IV
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1. To evaluate the effects of tranexamic acid on blood loss in patients with pre eclampsia undergoing LSCS <br/ ><br>Timepoint: post-operative period within 48 hours
- Secondary Outcome Measures
Name Time Method 1. To evaluate the effect of tranexamic acid on the incidence of PPH in patients with pre-eclampsia patients undergoing LSCS. <br/ ><br>2. To evaluate the effect of tranexamic acid on the requirement of blood & blood products in pre-eclampsia patients undergoing LSCS. <br/ ><br>3. To evaluate the effect of tranexamic acid on the Haemoglobin in pre-eclampsia patients undergoing LSCS. <br/ ><br>4. To evaluate the safety of tranexamic acid in patients with pre-eclampsia undergoing LSCS. <br/ ><br>Timepoint: post-operative period within 48 hours